Tango Therapeutics President, R&D Adam Crystal reports sale of $125,000 in common shares
TNGX•Adam Crystal sold 5,000 Tango Therapeutics shares at $25 each and exercised options for 5,000 shares at $2.91 each on Nov. 11, 2026. After the transactions, he directly held 115,743 shares and 308,090 stock options.
1. Share transactions
Tango Therapeutics President, R&D Adam Crystal sold 5,000 common shares at $25 each on Nov. 11, 2026, for $125,000. On the same date, he exercised stock options for 5,000 shares at $2.91 per share. After the transactions, Crystal directly held 115,743 common shares and 308,090 stock options.
